To mitigate the toxic effects of antimitotic agents, several safety measures and precautions are employed. These include dose adjustment, therapeutic monitoring, and supportive care to manage side effects. Additionally, researchers are continuously exploring novel formulations and delivery systems, such as nanoparticle-based drug delivery, to enhance selectivity and reduce systemic toxicity. Monitoring patient response and adjusting treatment protocols based on individual tolerance and side effects are also crucial components of managing toxicities associated with these agents.
